Rectal gastrointestinal stromal tumor (GIST ) in the era of imatinib: Organ preservation and improved oncologic outcome
Annals of Surgical Oncology Oct 27, 2017
Cavnar MJ, et al. - Researchers sought to investigate the outcome for rectal GIST in the era of imatinib. For patients with rectal GIST, the use of imatinib was associated with organ preservation and improved oncologic outcome.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
